Drug intelligence / Profile preview

tetanus toxoid + diphtheria toxoid (IBSS Biomed S.A.)

Development stage
Unknown
Lead developer
IBSS Biomed
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Clodivac is a bivalent booster vaccine developed by IBSS Biomed S.A. for active immunization against tetanus and diphtheria in adults. It consists of purified tetanus toxoid and a reduced dose of purified diphtheria toxoid, both adsorbed onto aluminum hydroxide to enhance immunogenicity. The vaccine works by stimulating the production of specific antitoxins that neutralize the toxins produced by *Clostridium tetani* and *Corynebacterium diphtheriae*. It is typically administered as a booster dose to maintain long-term immunity in individuals previously vaccinated with a primary series. Clinical trials have evaluated its safety and immunogenicity compared to other established Td vaccines.

Brand names
Clodivac
Other names
Td vaccineAdsorbed tetanus and diphtheria vaccine
02

Targets

TT (Tetanus toxoid)

Beyond the preview

Go deeper on tetanus toxoid + diphtheria toxoid (IBSS Biomed S.A.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tetanus toxoid + diphtheria toxoid (IBSS Biomed S.A.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call